
Human Wilms tumor protein 10-18, ALLPAVPSL
Description
About Human Wilms tumor protein 10-18, ALLPAVPSL
The Human Wilms tumor protein Peptide (IEDB: 614031) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Wilms tumor protein Peptide, H-ALLPAVPSL-OH (Uniprot: P19544 aa: 10-18) from JPT is produced under strict quality control and quality management.
Human Wilms tumor protein 10-18, ALLPAVPSL - Specifications
- Peptide sequence: H-ALLPAVPSL-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Bladder cancer
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Peptide Synthesis Services!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Wilms tumor protein 10-18, ALLPAVPSL
References:
Read References with JPT’s Antigen Peptides
Human Wilms tumor protein 10-18, ALLPAVPSL has been described in:
WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma., J Immunother Cancer, 2022 (PMID: 35728869)
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency., Sci Transl Med, 2022 (PMID: 35138909)
Documentation
Documentation for Human Wilms tumor protein 10-18, ALLPAVPSL
Properties
Properties of Human Wilms tumor protein 10-18, ALLPAVPSL
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Bladder cancer |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Wilms tumor protein 10-18, ALLPAVPSL
Information | Values |
---|---|
Sequence: | H-ALLPAVPSL-OH |
Specifications: | 9mer peptide as TFA salt |